Alnylam Pharmaceuticals
ALNY
#775
Rank
S$41.56 B
Marketcap
S$310.66
Share price
-0.82%
Change (1 day)
-46.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company